Institutional Ownership Halozyme Therapeutics, Inc. (HALO)
This table provides information about the institutional ownership of Halozyme Therapeutics, Inc. (HALO). We have compiled data on the 604 institutions that hold shares in the stock, with a total of 127 Million shares, which have been reported (via 13F filing form) to have a value of $9.62 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
17,619,937
shares
|
$1.34 Billion
0.02% of portfolio
|
Q2 2024
Reduced 3.41%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
12,245,602
shares
|
$932 Million
0.01% of portfolio
|
Q2 2025
Reduced 4.57%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
5,935,045
shares
|
$451 Million
0.01% of portfolio
|
Q2 2025
Reduced 1.95%
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
3,465,889
shares
|
$264 Million
0.03% of portfolio
|
Q2 2025
Reduced 11.0%
|
|
Snyder Capital Management L P
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
3,397,697
shares
|
$258 Million
3.92% of portfolio
|
Q2 2025
Reduced 7.53%
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Aug 13, 2025 Q2 2025 |
2,541,181
shares
|
$193 Million
0.1% of portfolio
|
Q2 2025
Added 127.81%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
2,474,825
shares
|
$188 Million
0.01% of portfolio
|
Q1 2025
Added 3.66%
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
2,455,268
shares
|
$187 Million
0.04% of portfolio
|
Q2 2025
Reduced 23.63%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
2,432,509
shares
|
$185 Million
0.01% of portfolio
|
Q2 2025
Reduced 23.25%
|
|
Macquarie Group LTD
Australia, C3 |
Aug 14, 2025 Q2 2025 |
2,083,392
shares
|
$158 Million
0.14% of portfolio
|
Q2 2025
Reduced 22.1%
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
2,067,911
shares
|
$157 Million
0.01% of portfolio
|
Q2 2025
Reduced 10.64%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
2,014,727
shares
|
$153 Million
0.03% of portfolio
|
Q2 2025
Reduced 0.71%
|
|
Congress Asset Management CO
|
Jul 16, 2025 Q2 2025 |
1,835,411
shares
|
$140 Million
0.68% of portfolio
|
Q2 2025
Reduced 13.94%
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
1,768,601
shares
|
$135 Million
0.01% of portfolio
|
Q2 2025
Reduced 8.43%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,530,519
shares
|
$116 Million
0.02% of portfolio
|
Q4 2024
Reduced 0.56%
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
1,524,387
shares
|
$116 Million
0.01% of portfolio
|
Q2 2025
Added 334.01%
|
|
Gw&K Investment Management, LLC
Boston, MA |
Aug 11, 2025 Q2 2025 |
1,424,516
shares
|
$108 Million
0.66% of portfolio
|
Q2 2025
Reduced 2.76%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,367,702
shares
|
$104 Million
0.01% of portfolio
|
Q2 2025
Reduced 9.96%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
1,342,831
shares
|
$102 Million
0.01% of portfolio
|
Q2 2025
Reduced 23.22%
|
|
Caisse De Depot Et Placement Du Quebec
Montreal, A8 |
Aug 14, 2025 Q2 2025 |
1,341,220
shares
|
$102 Million
0.15% of portfolio
|
Q2 2025
Added 47.36%
|
|
Stephens Investment Management Group LLC
|
Jul 30, 2025 Q2 2025 |
1,291,977
shares
|
$98.3 Million
0.95% of portfolio
|
Q2 2025
Reduced 3.37%
|
|
Lsv Asset Management
Chicago, IL |
Aug 11, 2025 Q2 2025 |
1,255,240
shares
|
$95.5 Million
0.16% of portfolio
|
Q2 2025
Added 40.22%
|
|
Fuller & Thaler Asset Management, Inc.
San Mateo, CA |
Aug 14, 2025 Q2 2025 |
1,243,008
shares
|
$94.6 Million
0.24% of portfolio
|
Q2 2025
Added 10.0%
|
|
Groupama Asset Managment
Paris, I0 |
Aug 13, 2025 Q2 2025 |
1,200,000
shares
|
$91.3 Million
0.02% of portfolio
|
Q3 2024
New holding
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
May 14, 2025 Q1 2025 |
1,138,651
shares
|
$86.6 Million
0.12% of portfolio
|
Q1 2025
Reduced 17.07%
|